Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in

Markets

Market

AUROBINDO PHARMA LTD.

  • NSE CodeAUROPHARMAEQ
  • BSE Code524804
  • ISININE406A01037
  • IndustryPharmaceuticals


Company Information

Management

Mr. Santhanam Subramanian

Chief Financial Officer

Mr. B Adi Reddy

Co. Secretary & Compl. Officer

Incorporation Year

26/12/1986

Registered Address

Registered Office : Plot No.2, Maitri Vihar, Ameerpet,
Hyderabad, Telangana - 500038
Tel: 040-23736370, 23747340
Fax: 040-23741080

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

info@aurobindo.com

Website

www.aurobindo.com

Listing

BSE, MCXSX, NSE

Corporate News

Aurobindo Pharma Q2 net profit up 24.46% at Rs 723.58...

04-Nov-2026|9:00PM

The company reported standalone net profit of Rs 723.58 crore for the quart

Aurobindo Pharma - Financial Results For The Quarter ...

04-Nov-2026|8:49PM

Submission of Financial results for the Quarter and Half year ended Septemb

Aurobindo Pharma - Change in Director(s)

04-Nov-2026|8:43PM

Aurobindo Pharma Limited has informed the Exchange regarding Change in Dire

Aurobindo Pharma - Announcement under Regulation 30 (...

04-Nov-2026|8:39PM

Reappointment of Mr. M. R. Kumar as Independent Director of the Company for

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug108.97308.98
Aarti Drug457.854,178.80
Aarti Pharma938.308,508.49
Abbott India26,930.0057,224.37
Accent Micro617.501,481.32
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
HDFC Mid Cap ..2231.242.19
Quant ELSS Ta..1112.268.49
Quant Mid Cap..819.7610.71
SBI Large &am..785.841.94
Quant Multi C..711.829.49
More

Board Meetings

DatePurpose
04/11/2026Quarterly Results &..
05/08/2026Quarterly Results
21/05/2026Audited Results
06/04/2026Buy Back of Shares
09/02/2026Quarterly Results
More